.jpg)
Mazor Robotics is a biomed company that is engaged in the field of surgical robotic systems. It develops and manufactures surgical robotic guidance systems for spine and brain surgeries. The company was established in 2000 and, in 2007, began to be traded on the Tel-Aviv Stock Exchange (TASE). In 2013, the company listed its shares on the NASDAQ exchange in the United States and is now dual-listed on both markets.
Ori Hadomi, CEO of Mazor Robotics: “The inclusion of Mazor in the TA-35 Index, which is considered to be TASE’s most prestigious equities index, represents a moment of satisfaction and another important milestone in Mazor Robotics’ achievements. Mazor’s joining the group of the 35 largest companies in the Israeli capital market, in terms of market value, reflects the recognition earned by the company and the technology that we have developed with the aid of our investors in Israel and throughout the world.
This expression of confidence honors the perseverance, determination and professionalism of Mazor’s employees over many years in realizing the vision of bringing Mazor to patients throughout the world, by means of technological innovation in the field of image-guided robotics. In the name of all the company’s employees, who are spread over three continents, I would like to express my appreciation for the confidence shown in us. I’m proud to be part of an Israeli company that was established in Israel and is managed from there, and which has built itself up to be a global pioneer and a market leader in the field of surgical robotics for spine and brain surgery and is committed to setting lofty goals and their achievement”.
Jonathan Adereth, Chairman of Mazor Robotics: “We are excited today at being accepted into this elite capital market group. Through considerable hard work, we have built a magnificent company and have earned the recognition of the medical world. This is the time and place to thank TASE for providing us with a portal to the Israeli capital market. This was the springboard that enabled us to reach the global capital market”.
Sharon Lavy, Head of TASE’s Trading and Indices Unit: “The company began to be traded as a relatively small company and now has a market value of some NIS 6 billion, almost 50 times the company’s value on the day it was first listed. In little more than a decade from its first listing, the company has joined the 35 largest companies on TASE. The company serves as an excellent example of a “blue-and-white”, biomed company that has been able to successfully grow with assistance from TASE, and currently more than 80% of the company’s investors are institutional investors and the general public. In 2017, the company’s share yield stood at 107%.
I wish the company further success since, thanks to your products, you are making our world a better place”.
Pictured from right to left:
Ittai Ben-Zeev, TASE’s CEO; Jonathan Adereth, Chairman of Mazor Robotics’ Board of Directors
Sharon Levita, Mazor Robotics’ CFO and VP Business Operations: Ori Hadomi, Mazo Robotics ’CEO
And Sharon Lavy, Head of TASE’s Trading and Indices Unit at TASE
Photo credit: Omer Messinger, for no financial consideration.
Ittai Ben-Zeev, TASE’s CEO; Jonathan Adereth, Chairman of Mazor Robotics’ Board of Directors
Sharon Levita, Mazor Robotics’ CFO and VP Business Operations: Ori Hadomi, Mazo Robotics ’CEO
And Sharon Lavy, Head of TASE’s Trading and Indices Unit at TASE
Photo credit: Omer Messinger, for no financial consideration.
